Craneware plc (AIM:CRW)
London · Delayed Price · Currency is GBP · Price in GBX 1,455.00
-10.00 (-0.68%)
At close: Feb 13, 2026
Craneware Market Cap
Craneware has a market cap or net worth of 510.29 million as of February 13, 2026. Its market cap has decreased by -23.30% in one year.
Market Cap
510.29M
Enterprise Value
492.58M
Revenue
150.11M
Ranking
n/a
PE Ratio
36.11
Stock Price
1,455.00
Market Cap Chart
Since September 13, 2007, Craneware's market cap has increased from 27.00M to 510.29M, an increase of 1,790.31%. That is a compound annual growth rate of 17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 513.80M | -24.09% |
| Dec 31, 2025 | 676.88M | -8.39% |
| Dec 31, 2024 | 738.88M | 20.69% |
| Dec 29, 2023 | 612.23M | -3.93% |
| Dec 30, 2022 | 637.29M | -26.03% |
| Dec 31, 2021 | 861.52M | 41.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 234.47B |
| GSK plc | 85.92B |
| Haleon | 36.22B |
| Smith & Nephew | 11.10B |
| Oxford Biomedica | 954.58M |
| Spire Healthcare Group | 824.86M |
| Allergy Therapeutics | 644.85M |
| Advanced Medical Solutions Group | 466.09M |